Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.
Find out more.News
-
May 30, 2013
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Jefferies 2013 Global Healthcare Conference
-
May 29, 2013
-
May 29, 2013
Sucampo Pharmaceuticals Achieves Orphan Designation for Unoprostone Isopropyl for Treatment of Retinitis Pigmentosa by European Medicines Agency
-
May 15, 2013